Molina Healthcare (MOH)
Molina Healthcare on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on NYSE, classified by the SEC as hospital & medical service plans.
3.0M
Short interest
settlement 2026-10-15
3.7
Days to cover
-1.1 days vs prior
47.7%
Short share of volume
2026-10-28
386
Fails to deliver
settlement 2026-09-24
Thu 4 Feb
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-10-28.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in MOH is 2,993,244 shares, down 215,213 shares over the last month. Over the last 48 readings it ranged from 888,429 shares (31 October 2024) to 4,386,502 shares (28 November 2025). At the reported average volume of 814K shares a day that is 3.7 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/moh" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 2,993,244 | +3.7% | 814,330 | 3.68 |
| 2026-09-30 | 2,887,217 | -10.0% | 606,938 | 4.76 |
| 2026-09-15 | 3,208,457 | +4.2% | 549,211 | 5.84 |
| 2026-08-31 | 3,079,899 | +10.7% | 625,710 | 4.92 |
| 2026-08-14 | 2,781,600 | -5.3% | 577,692 | 4.82 |
| 2026-07-31 | 2,935,657 | -12.0% | 2,053,569 | 1.43 |
| 2026-07-15 | 3,334,595 | +1.4% | 954,829 | 3.49 |
| 2026-06-30 | 3,288,537 | +9.7% | 1,207,783 | 2.72 |
| 2026-06-15 | 2,998,122 | +18.4% | 984,026 | 3.05 |
| 2026-05-29 | 2,532,174 | -12.9% | 944,687 | 2.68 |
| 2026-05-15 | 2,908,337 | -18.3% | 933,018 | 3.12 |
| 2026-04-30 | 3,560,764 | +15.7% | 1,724,357 | 2.06 |
| 2026-04-15 | 3,078,804 | -10.9% | 1,081,580 | 2.85 |
| 2026-03-31 | 3,456,307 | +6.5% | 2,426,074 | 1.42 |
| 2026-03-13 | 3,244,602 | -8.6% | 1,313,263 | 2.47 |
| 2026-02-27 | 3,548,912 | -5.8% | 1,800,507 | 1.97 |
| 2026-02-13 | 3,767,698 | +30.4% | 2,978,126 | 1.27 |
| 2026-01-30 | 2,889,851 | -5.0% | 1,477,927 | 1.96 |
| 2026-01-15 | 3,042,371 | -15.8% | 1,338,748 | 2.27 |
| 2025-12-31 | 3,614,717 | -0.2% | 1,346,482 | 2.68 |
| 2025-12-15 | 3,621,816 | -17.4% | 1,419,977 | 2.55 |
| 2025-11-28 | 4,386,502 | +13.7% | 2,309,856 | 1.90 |
| 2025-11-14 | 3,856,991 | +22.8% | 1,740,067 | 2.22 |
| 2025-10-31 | 3,140,447 | -2.5% | 2,294,523 | 1.37 |
| 2025-10-15 | 3,221,202 | -4.7% | 883,391 | 3.65 |
| 2025-09-30 | 3,379,486 | +10.4% | 1,132,295 | 2.98 |
| 2025-09-15 | 3,061,574 | +4.7% | 1,346,395 | 2.27 |
| 2025-08-29 | 2,924,784 | +30.4% | 1,575,496 | 1.86 |
| 2025-08-15 | 2,243,752 | +28.0% | 1,475,508 | 1.52 |
| 2025-07-31 | 1,752,395 | +62.8% | 2,846,103 | 1.00 |
| 2025-07-15 | 1,076,291 | -7.7% | 1,309,583 | 1.00 |
| 2025-06-30 | 1,166,072 | -5.9% | 620,184 | 1.88 |
| 2025-06-13 | 1,239,693 | +16.3% | 541,146 | 2.29 |
| 2025-05-30 | 1,066,347 | -2.0% | 570,717 | 1.87 |
| 2025-05-15 | 1,087,759 | +13.9% | 611,205 | 1.78 |
| 2025-04-30 | 954,814 | -26.6% | 1,041,338 | 1.00 |
| 2025-04-15 | 1,300,749 | +1.7% | 826,015 | 1.57 |
| 2025-03-31 | 1,278,963 | -26.7% | 528,994 | 2.42 |
| 2025-03-14 | 1,745,479 | +1.5% | 861,714 | 2.03 |
| 2025-02-28 | 1,719,736 | +22.8% | 1,097,630 | 1.57 |
| 2025-02-14 | 1,400,778 | +34.5% | 885,439 | 1.58 |
| 2025-01-31 | 1,041,289 | -8.8% | 612,770 | 1.70 |
| 2025-01-15 | 1,141,548 | +3.8% | 440,492 | 2.59 |
| 2024-12-31 | 1,099,822 | +5.4% | 573,073 | 1.92 |
| 2024-12-13 | 1,043,798 | +8.3% | 665,381 | 1.57 |
| 2024-11-29 | 963,850 | -3.4% | 695,787 | 1.39 |
| 2024-11-15 | 997,355 | +12.3% | 754,413 | 1.32 |
| 2024-10-31 | 888,429 | -24.3% | 1,206,499 | 1.00 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 28 October 2026, the short share of MOH volume is 47.7%, down 8.8 points over the last five sessions. Over the last 30 readings it ranged from 29.3% (15 October 2026) to 68.8% (22 October 2026). The latest reading is 4.1 points below the 30-session average of 51.7%, on 177K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-28 | 85K | 177K | 47.7% | 0 |
| 2026-10-27 | 172K | 267K | 64.6% | 0 |
| 2026-10-26 | 191K | 328K | 58.3% | 196 |
| 2026-10-23 | 305K | 552K | 55.3% | 15 |
| 2026-10-22 | 545K | 792K | 68.8% | 103 |
| 2026-10-21 | 217K | 385K | 56.5% | 500 |
| 2026-10-20 | 172K | 357K | 48.3% | 11 |
| 2026-10-19 | 82K | 190K | 43.4% | 0 |
| 2026-10-16 | 93K | 306K | 30.4% | 0 |
| 2026-10-15 | 108K | 368K | 29.3% | 13 |
| 2026-10-14 | 257K | 594K | 43.4% | 0 |
| 2026-10-13 | 264K | 448K | 58.9% | 247 |
| 2026-10-12 | 158K | 253K | 62.5% | 33 |
| 2026-10-09 | 115K | 229K | 50.4% | 491 |
| 2026-10-08 | 114K | 216K | 52.7% | 0 |
| 2026-10-07 | 101K | 176K | 57.5% | 0 |
| 2026-10-06 | 117K | 184K | 63.6% | 0 |
| 2026-10-05 | 165K | 389K | 42.3% | 236 |
| 2026-10-02 | 132K | 240K | 54.9% | 0 |
| 2026-10-01 | 255K | 443K | 57.6% | 70 |
| 2026-09-30 | 73K | 195K | 37.3% | 0 |
| 2026-09-29 | 115K | 259K | 44.5% | 436 |
| 2026-09-28 | 117K | 239K | 49.0% | 0 |
| 2026-09-25 | 144K | 246K | 58.5% | 0 |
| 2026-09-24 | 143K | 262K | 54.8% | 67 |
| 2026-09-23 | 125K | 249K | 50.0% | 2 |
| 2026-09-22 | 98K | 192K | 50.9% | 0 |
| 2026-09-21 | 80K | 162K | 49.5% | 0 |
| 2026-09-18 | 80K | 166K | 48.3% | 0 |
| 2026-09-17 | 134K | 213K | 62.9% | 63 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 24 September 2026, the fails-to-deliver balance in MOH is 386 shares, up 127 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (12 May 2026) to 53,757 shares (28 July 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-24 | 386 | $189.37 | $73K |
| 2026-09-21 | 259 | $200.79 | $52K |
| 2026-08-24 | 69 | $200.29 | $14K |
| 2026-08-18 | 88 | $203.06 | $18K |
| 2026-08-11 | 87 | $198.84 | $17K |
| 2026-08-05 | 447 | $191.36 | $86K |
| 2026-07-29 | 52,693 | $200.34 | $10.6M |
| 2026-07-28 | 53,757 | $199.48 | $10.7M |
| 2026-07-27 | 24 | $197.55 | $5K |
| 2026-07-24 | 200 | $200.29 | $40K |
| 2026-07-23 | 200 | $221.74 | $44K |
| 2026-07-22 | 200 | $226.54 | $45K |
| 2026-07-20 | 361 | $225.37 | $81K |
| 2026-07-16 | 7 | $233.36 | $2K |
| 2026-06-29 | 199 | $229.74 | $46K |
| 2026-06-26 | 3,228 | $216.04 | $697K |
| 2026-06-22 | 1,227 | $195.37 | $240K |
| 2026-06-16 | 2,320 | $201.87 | $468K |
| 2026-06-15 | 13,533 | $200.28 | $2.7M |
| 2026-06-12 | 41,286 | $193.20 | $8.0M |
| 2026-06-11 | 36,840 | $197.89 | $7.3M |
| 2026-06-03 | 25 | $179.86 | $4K |
| 2026-05-29 | 34,705 | $178.02 | $6.2M |
| 2026-05-26 | 479 | $184.14 | $88K |
| 2026-05-21 | 12 | $182.24 | $2K |
| 2026-05-18 | 120 | $184.99 | $22K |
| 2026-05-15 | 54 | $186.80 | $10K |
| 2026-05-12 | 1 | $185.19 | $185 |
| 2026-04-24 | 1,456 | $174.70 | $254K |
| 2026-04-20 | 2 | $148.97 | $298 |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for MOH in the last 90 days. The most recent filings are listed below. Latest filing: Schapiro Richard M (Director) on 2026-10-01.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Schapiro Richard M | Director | Grant | 304 | $180.85 | $55K | 13K |
| 2026-10-01 | ZORETIC RICHARD C | Director | Grant | 304 | $180.85 | $55K | 10K |
| 2026-10-01 | SOISTMAN FRANCIS S JR | Director | Grant | 304 | $180.85 | $55K | 1K |
| 2026-10-01 | WOLF DALE B | Director | Grant | 304 | $180.85 | $55K | 16K |
| 2026-10-01 | ORLANDO STEVEN J | Director | Grant | 304 | $180.85 | $55K | 18K |
| 2026-10-01 | ROMNEY RONNA | Director | Grant | 304 | $180.85 | $55K | 18K |
| 2026-10-01 | Lockhart Stephen H | Director | Grant | 304 | $180.85 | $55K | 5K |
| 2026-10-01 | GROHOWSKI LEO P | Director | Grant | 304 | $180.85 | $55K | 2K |
| 2026-10-01 | BRASIER BARBARA L | Director | Grant | 304 | $180.85 | $55K | 6K |
| 2026-07-01 | Schapiro Richard M | Director | Grant | 237 | $232.55 | $55K | 12K |
| 2026-07-01 | ZORETIC RICHARD C | Director | Grant | 237 | $232.55 | $55K | 9K |
| 2026-07-01 | SOISTMAN FRANCIS S JR | Director | Grant | 237 | $232.55 | $55K | 907 |
| 2026-07-01 | WOLF DALE B | Director | Grant | 237 | $232.55 | $55K | 16K |
| 2026-07-01 | ORLANDO STEVEN J | Director | Grant | 237 | $232.55 | $55K | 18K |
| 2026-07-01 | ROMNEY RONNA | Director | Grant | 237 | $232.55 | $55K | 18K |
| 2026-07-01 | Lockhart Stephen H | Director | Grant | 237 | $232.55 | $55K | 4K |
| 2026-07-01 | GROHOWSKI LEO P | Director | Grant | 237 | $232.55 | $55K | 2K |
| 2026-07-01 | Bacon Debra | EVP, Medicaid | Tax withholding | 183 | $232.55 | $43K | 22K |
| 2026-07-01 | BRASIER BARBARA L | Director | Grant | 237 | $232.55 | $55K | 6K |
| 2026-06-30 | WOYS JAMES | Chief Operating Officer | Grant | 144 | $147.51 | $21K | 90K |
| 2026-06-30 | Barlow Jeff D. | Chief Legal Officer | Grant | 138 | $147.51 | $20K | 67K |
| 2026-06-30 | Bacon Debra | EVP, Medicaid | Grant | 23 | $147.51 | $3K | 22K |
| 2026-05-14 | HEBERT MAURICE | Chief Accounting Officer | Sell | 600 | $191.55 | $115K | 13K |
| 2026-05-11 | Barlow Jeff D. | Chief Legal Officer | Sell | 18K | $186.12 | $3.3M | 67K |
| 2026-05-06 | SOISTMAN FRANCIS S JR | Director | Grant | 170 | $197.44 | $34K | 670 |
| 2026-04-01 | Schapiro Richard M | Director | Grant | 405 | $135.82 | $55K | 12K |
| 2026-04-01 | ZORETIC RICHARD C | Director | Grant | 405 | $135.82 | $55K | 9K |
| 2026-04-01 | WOLF DALE B | Director | Grant | 405 | $135.82 | $55K | 15K |
| 2026-04-01 | ORLANDO STEVEN J | Director | Grant | 405 | $135.82 | $55K | 18K |
| 2026-04-01 | ROMNEY RONNA | Director | Grant | 405 | $135.82 | $55K | 18K |
| 2026-04-01 | Lockhart Stephen H | Director | Grant | 405 | $135.82 | $55K | 4K |
| 2026-04-01 | GROHOWSKI LEO P | Director | Grant | 405 | $135.82 | $55K | 1K |
| 2026-04-01 | BRASIER BARBARA L | Director | Grant | 405 | $135.82 | $55K | 6K |
| 2026-03-12 | ROMNEY RONNA | Director | Sell | 506 | $146.92 | $74K | 17K |
| 2026-03-01 | Zubretsky Joseph M | President & CEO | Grant | 66K | $145.75 | $9.7M | 99K |
| 2026-03-01 | Zubretsky Joseph M | President & CEO | Tax withholding | 9K | $154.05 | $1.3M | 33K |
| 2026-03-01 | WOYS JAMES | Chief Operating Officer | Grant | 17K | $145.75 | $2.5M | 90K |
| 2026-03-01 | WOYS JAMES | Chief Operating Officer | Tax withholding | 1K | $154.05 | $202K | 73K |
| 2026-03-01 | Keim Mark Lowell | Chief Financial Officer | Grant | 26K | $145.75 | $3.8M | 83K |
| 2026-03-01 | Keim Mark Lowell | Chief Financial Officer | Tax withholding | 2K | $154.05 | $356K | 57K |
| 2026-03-01 | HEBERT MAURICE | Chief Accounting Officer | Grant | 2K | $145.75 | $300K | 13K |
| 2026-03-01 | HEBERT MAURICE | Chief Accounting Officer | Tax withholding | 272 | $154.05 | $42K | 11K |
| 2026-03-01 | HEBERT MAURICE | Chief Accounting Officer | Tax withholding | 229 | $154.05 | $35K | 12K |
| 2026-03-01 | HEBERT MAURICE | Chief Accounting Officer | Grant | 650 | $154.05 | $100K | 12K |
| 2026-03-01 | Barlow Jeff D. | Chief Legal Officer | Grant | 14K | $145.75 | $2.0M | 85K |
| 2026-03-01 | Barlow Jeff D. | Chief Legal Officer | Tax withholding | 2K | $154.05 | $252K | 71K |
| 2026-03-01 | Bacon Debra | EVP, Medicaid | Grant | 10K | $145.75 | $1.4M | 22K |
| 2026-03-01 | Bacon Debra | EVP, Medicaid | Tax withholding | 716 | $154.05 | $110K | 12K |
| 2026-02-11 | ZORETIC RICHARD C | Director | Buy | 800 | $125.16 | $100K | 9K |
| 2026-01-01 | Schapiro Richard M | Director | Grant | 317 | $173.54 | $55K | 12K |
| 2026-01-01 | ZORETIC RICHARD C | Director | Grant | 317 | $173.54 | $55K | 8K |
| 2026-01-01 | WOLF DALE B | Director | Grant | 317 | $173.54 | $55K | 15K |
| 2026-01-01 | ORLANDO STEVEN J | Director | Grant | 317 | $173.54 | $55K | 17K |
| 2026-01-01 | ROMNEY RONNA | Director | Grant | 317 | $173.54 | $55K | 18K |
| 2026-01-01 | Lockhart Stephen H | Director | Grant | 317 | $173.54 | $55K | 4K |
| 2026-01-01 | GROHOWSKI LEO P | Director | Grant | 317 | $173.54 | $55K | 900 |
| 2026-01-01 | BRASIER BARBARA L | Director | Grant | 317 | $173.54 | $55K | 5K |
| 2025-12-31 | Bacon Debra | EVP, Medicaid | Grant | 22 | $147.51 | $3K | 13K |
| 2025-11-24 | Schapiro Richard M | Director | Sell | 357 | $143.02 | $51K | 11K |
| 2025-10-01 | Schapiro Richard M | Director | Grant | 285 | $192.79 | $55K | 12K |
| 2025-10-01 | ZORETIC RICHARD C | Director | Grant | 285 | $192.79 | $55K | 8K |
| 2025-10-01 | WOLF DALE B | Director | Grant | 285 | $192.79 | $55K | 15K |
| 2025-10-01 | ORLANDO STEVEN J | Director | Grant | 285 | $192.79 | $55K | 17K |
| 2025-10-01 | ROMNEY RONNA | Director | Grant | 285 | $192.79 | $55K | 17K |
| 2025-10-01 | Lockhart Stephen H | Director | Grant | 285 | $192.79 | $55K | 3K |
| 2025-10-01 | GROHOWSKI LEO P | Director | Grant | 285 | $192.79 | $55K | 583 |
| 2025-10-01 | BRASIER BARBARA L | Director | Grant | 285 | $192.79 | $55K | 5K |
| 2025-08-06 | ROMNEY RONNA | Director | Sell | 700 | $153.74 | $108K | 17K |
| 2025-08-04 | WOYS JAMES | Chief Operating Officer | Buy | 5K | $156.36 | $704K | 74K |
| 2025-08-04 | WOYS JAMES | Chief Operating Officer | Buy | 6K | $155.59 | $856K | 70K |
| 2025-07-01 | ZORETIC RICHARD C | Director | Grant | 180 | $306.29 | $55K | 7K |
| 2025-07-01 | WOLF DALE B | Director | Grant | 180 | $306.29 | $55K | 14K |
| 2025-07-01 | Schapiro Richard M | Director | Grant | 180 | $306.29 | $55K | 11K |
| 2025-07-01 | ROMNEY RONNA | Director | Grant | 180 | $306.29 | $55K | 18K |
| 2025-07-01 | ORLANDO STEVEN J | Director | Grant | 180 | $306.29 | $55K | 17K |
| 2025-07-01 | Lockhart Stephen H | Director | Grant | 180 | $306.29 | $55K | 3K |
| 2025-07-01 | GROHOWSKI LEO P | Director | Grant | 180 | $306.29 | $55K | 298 |
| 2025-07-01 | Bacon Debra | EVP, Medicaid | Tax withholding | 183 | $306.29 | $56K | 13K |
| 2025-07-01 | BRASIER BARBARA L | Director | Grant | 180 | $306.29 | $55K | 5K |
| 2025-06-30 | WOYS JAMES | Chief Operating Officer | Grant | 85 | $247.39 | $21K | 64K |
| 2025-06-30 | Barlow Jeff D. | Chief Legal Officer | Grant | 85 | $247.39 | $21K | 73K |
| 2025-06-30 | Bacon Debra | EVP, Medicaid | Grant | 41 | $247.39 | $10K | 13K |
| 2025-05-21 | WOLF DALE B | Director | Sell | 100 | $320.51 | $32K | 16K |
| 2025-05-21 | WOLF DALE B | Director | Sell | 900 | $323.27 | $291K | 14K |
| 2025-05-21 | WOLF DALE B | Director | Sell | 400 | $322.23 | $129K | 15K |
| 2025-05-21 | WOLF DALE B | Director | Sell | 100 | $324.42 | $32K | 14K |
| 2025-05-05 | ORLANDO STEVEN J | Director | Sell | 1K | $318.58 | $319K | 17K |
| 2025-05-01 | GROHOWSKI LEO P | Director | Grant | 118 | $313.04 | $37K | 118 |
| 2025-04-30 | Zubretsky Joseph M | President & CEO | Sell | 1K | $324.70 | $357K | 258K |
| 2025-04-30 | Zubretsky Joseph M | President & CEO | Sell | 86K | $320.00 | $27.6M | 259K |
| 2025-04-29 | Schapiro Richard M | Director | Sell | 669 | $320.50 | $214K | 11K |
| 2025-04-01 | BRASIER BARBARA L | Director | Grant | 168 | $327.71 | $55K | 4K |
| 2025-04-01 | COOPERMAN DANIEL | Director | Grant | 56 | $327.71 | $18K | 6K |
| 2025-04-01 | Lockhart Stephen H | Director | Grant | 168 | $327.71 | $55K | 3K |
| 2025-04-01 | ORLANDO STEVEN J | Director | Grant | 168 | $327.71 | $55K | 18K |
| 2025-04-01 | ROMNEY RONNA | Director | Grant | 168 | $327.71 | $55K | 18K |
| 2025-04-01 | Schapiro Richard M | Director | Grant | 168 | $327.71 | $55K | 12K |
| 2025-04-01 | WOLF DALE B | Director | Grant | 168 | $327.71 | $55K | 16K |
| 2025-04-01 | ZORETIC RICHARD C | Director | Grant | 168 | $327.71 | $55K | 7K |
| 2025-03-03 | ORLANDO STEVEN J | Director | Sell | 1K | $301.33 | $301K | 17K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON4 Form 144 notices on file for MOH worth $3.6M at the prices reported; 0 in the last 90 days worth $0. Latest: MAURICE HEBERT filed on 2026-05-14 to sell 600 shares ($115K) from 2026-05-14.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-05-14 | MAURICE HEBERTOfficer | 600 | $115K | 0.001% | 2026-05-14 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-11 | JEFF D BARLOWOfficer | 18K | $3.3M | 0.034% | 2026-05-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-12 | ROMNEY RONNADirector | 506 | $74K | 0.001% | 2026-03-11 | Fidelity Brokerage Services LLC |
| 2025-11-24 | Schapiro Richard MDirector | 357 | $51K | 0.001% | 2025-11-24 | Piper Sandler and Co |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON9 holders report 5% or more of MOH in their latest filing, all on Schedule 13G (passive). The largest reported stake is BlackRock, Inc. at 9.2% of the class (4,805,370 shares), filed 2026-10-27 for an event on 2026-09-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-27 | 13G/Ano. 14 | BlackRock, Inc.parent holding company | 4.8M | 9.2% | 2026-09-30 |
| 2026-09-03 | 13G | Giovanni Agnelli B.V.parent holding company, corporation | 2.7M | 5.2% | 2026-08-28 |
| 2026-09-03 | 13G | Exor N.V.parent holding company, corporation | 2.7M | 5.2% | 2026-08-28 |
| 2026-09-03 | 13G | Lingotto Investment Management (UK) Limitedcorporation, non-US institution | 2.7M | 5.2% | 2026-08-28 |
| 2026-09-03 | 13G | Lingotto Investment Management LLPpartnership, non-US institution | 2.7M | 5.2% | 2026-08-28 |
| 2026-08-13 | 13G/Ano. 1 | AQR Capital Management, LLCinvestment adviser | 3.6M | 6.8% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 1 | AQR Capital Management Holdings, LLCparent holding company | 3.6M | 6.8% | 2026-06-30 |
| 2026-08-12 | 13G/Ano. 14 | Capital World Investorsinvestment adviser | 2.6M | 4.9% | 2026-06-30 |
| 2026-08-06 | 13G/Ano. 1 | FMR LLCparent holding company | 1.9M | 3.6% | 2026-06-30 |
| 2026-08-06 | 13G/Ano. 1 | Abigail P. Johnsonindividual | 1.9M | 3.6% | 2026-06-30 |
| 2026-04-30 | 13G | Vanguard Capital Managementinvestment adviser | 2.7M | 5.2% | 2026-03-31 |
| 2026-04-29 | 13G | Vanguard Portfolio Managementinvestment adviser | 2.8M | 5.4% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 11 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-02-17 | 13G/Ano. 1 | T. Rowe Price Associates, Inc.investment adviser | 994K | 1.9% | 2025-12-31 |
13F holders
Tracked managers holding MOH at their latest 13F. JSON9 of the 30 tracked managers held MOH at their latest 13F, $1.42B in total at quarter-end prices. AQR Capital Management is the largest at $806.9M (0.3% of its portfolio) as of 2026-06-30. Over the prior quarter 6 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| AQR Capital Management | 2026-06-30 | 3.6M | $806.9M | 0.28% | +697K |
| Two Sigma Investments | 2026-06-30 | 1.3M | $289.6M | 0.21% | -84K |
| Baupost Group | 2026-06-30 | 634K | $144.9M | 2.68% | 0 |
| Renaissance Technologies | 2026-06-30 | 315K | $72.1M | 0.10% | +293K |
| D. E. Shaw & Co. | 2026-06-30 | 208K | $47.6M | 0.02% | +126K |
| Scion Asset Management | 2025-09-30 | 125K | $23.9M | 1.73% | new |
| Millennium Management | 2026-06-30 | 83K | $19.0M | 0.01% | +44K |
| Citadel Advisors | 2026-06-30 | 43K | $9.8M | 0.00% | -180K |
| Bridgewater Associates | 2026-06-30 | 8K | $1.9M | 0.01% | +6K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q3 FY 2026 (quarter ended 2026-09-30) Molina Healthcare reported revenue of $11.08B, down 3.4% from the same quarter a year earlier, and net income of $38.0M (0.73 diluted EPS). In FY 2025 it generated -$535.0M of operating cash flow and spent $1.00B on buybacks. As of 2026-09-30, cash was $4.48B against $3.77B of debt.
- Cash
- $4.48B
- Debt
- $3.77B
- Equity
- $4.16B
- Total assets
- $15.65B
- Shares outstanding
- 52,200,000
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q3 FY 2026 | 2026-09-30 | $11.08B | $38.0M | 0.3% | 0.73 |
| Q2 FY 2026 | 2026-06-30 | $10.87B | $60.0M | 0.6% | 1.19 |
| Q1 FY 2026 | 2026-03-31 | $10.80B | $14.0M | 0.1% | 0.27 |
| Q4 FY 2025derived | 2025-12-31 | $11.38B | -$160.0M | -1.4% | n/a |
| Q3 FY 2025 | 2025-09-30 | $11.48B | $79.0M | 0.7% | 1.51 |
| Q2 FY 2025 | 2025-06-30 | $11.43B | $255.0M | 2.2% | 4.75 |
| Q1 FY 2025 | 2025-03-31 | $11.15B | $298.0M | 2.7% | 5.45 |
| Q4 FY 2024derived | 2024-12-31 | $10.50B | $251.0M | 2.4% | n/a |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $45.43B | $472.0M | -$535.0M | $101.0M | $1.00B | n/a |
| FY 2024 | 2024-12-31 | $40.65B | $1.18B | $644.0M | $100.0M | $1.00B | n/a |
| FY 2023 | 2023-12-31 | $34.07B | $1.09B | $1.66B | $84.0M | $0 | n/a |
| FY 2022 | 2022-12-31 | $31.97B | $792.0M | $773.0M | $91.0M | $400.0M | n/a |
| FY 2021 | 2021-12-31 | $27.77B | $659.0M | $2.12B | $77.0M | $128.0M | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-09-30; shares outstanding as of 2026-10-16 from the cover page.
What this page is
Molina Healthcare in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Molina Healthcare (MOH), SEC CIK 1179929, listed on NYSE, classified by the SEC as hospital & medical service plans. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-28.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-24.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-05-14.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-27.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-09-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-10-21.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-01.JSON and CSV
- Company record
- EDGAR filing index for CIK 1179929Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as hospital & medical service plans
Other company pages
- CELCCelcuity
- CELHCelsius Holdings
- CFCF Industries Holdings
- CFGCitizens Financial Group
- CGCarlyle Group
- CHDChurch & Dwight
- CHKPCheck Point Software Technologies
- CHRWC.H. Robinson Worldwide
- CHTRCharter Communications
- CHWYChewy
- CHYMChime Financial
- CIENCiena
- CIFRCipher Digital
- CINFCincinnati Financial
- CLColgate-Palmolive
- CLFCleveland-Cliffs
Datasets
Frequently Asked Questions
How much of MOH is sold short?
2,993,244 shares were held short at the 2026-10-15 settlement, 3.7 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is MOH's daily short volume?
On 2026-10-28, 84,551 of the 177,372 MOH shares reported to FINRA were sold short, 47.7% of the day's reported volume. Short volume is a flow for one day, not a position.
Does MOH have fails to deliver?
The SEC's latest file shows 386 MOH shares failed to deliver at settlement 2026-09-24. Fails are reported per settlement date and published twice a month with a lag.
Are MOH insiders buying or selling?
No open-market insider trades were reported for MOH in the last 90 days. The most recent filings are listed below. Latest filing: Schapiro Richard M (Director) on 2026-10-01.
Have MOH insiders filed to sell?
4 Form 144 notices on file for MOH worth $3.6M at the prices reported; 0 in the last 90 days worth $0. Latest: MAURICE HEBERT filed on 2026-05-14 to sell 600 shares ($115K) from 2026-05-14.
Who owns 5% or more of MOH?
9 holders report 5% or more of MOH in their latest filing, all on Schedule 13G (passive). The largest reported stake is BlackRock, Inc. at 9.2% of the class (4,805,370 shares), filed 2026-10-27 for an event on 2026-09-30.
What did MOH report last quarter?
In Q3 FY 2026 (quarter ended 2026-09-30) Molina Healthcare reported revenue of $11.08B, down 3.4% from the same quarter a year earlier, and net income of $38.0M (0.73 diluted EPS). In FY 2025 it generated -$535.0M of operating cash flow and spent $1.00B on buybacks. As of 2026-09-30, cash was $4.48B against $3.77B of debt.
Which tracked 13F managers own MOH?
9 of the 30 tracked 13F managers held MOH shares at their latest filing, $1.42B in all. The largest: Cliff Asness's AQR Capital Management (3.6M shares, $806.9M), Two Sigma Investments (1.3M shares, $289.6M), Seth Klarman's Baupost Group (634K shares, $144.9M), Renaissance Technologies (315K shares, $72.1M), D. E. Shaw & Co. (208K shares, $47.6M), Michael Burry's Scion Asset Management (125K shares, $23.9M). The table above lists all 9.
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.